Terms: = Endocrine gland cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
19 results:
1. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
Xiong Y; Kong X; Mei H; Wang J; Zhou S
Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
[TBL] [Abstract] [Full Text] [Related]
2. [WHO Histological Classification of Pituitary Tumors].
Nishioka H
No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
[TBL] [Abstract] [Full Text] [Related]
3. PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/gata3 axis.
Wang H; Zhou Y; Zhang S; Qi YA; Wang M
Oncol Res; 2021; 29(4):275-289. PubMed ID: 37303939
[TBL] [Abstract] [Full Text] [Related]
4. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
Xie J; Wu ZB
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
[TBL] [Abstract] [Full Text] [Related]
5. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
Zhou Q; Yang HJ; Zuo MZ; Tao YL
J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
[TBL] [Abstract] [Full Text] [Related]
6. Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.
Hu L; Xie X
Diagn Pathol; 2020 Dec; 15(1):142. PubMed ID: 33317559
[TBL] [Abstract] [Full Text] [Related]
7. gata3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract] [Full Text] [Related]
8. Squamous cell carcinoma-A rare pancreatic exocrine malignancy.
Wahab A; Gonzalez JJ; Devarkonda V; Saint-Phard T; Singh T; Adekolujo OS
Cancer Biol Ther; 2019; 20(5):593-596. PubMed ID: 30388929
[TBL] [Abstract] [Full Text] [Related]
9. Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.
Magrill J; Karnezis AN; Tessier-Cloutier B; Talhouk A; Kommoss S; Cochrane D; Chow C; Cheng A; Soslow R; Hauptmann S; du Bois A; Pfisterer J; Gilks CB; Huntsman DG; Kommoss F
Int J Gynecol Pathol; 2019 Nov; 38(6):552-561. PubMed ID: 30059451
[TBL] [Abstract] [Full Text] [Related]
10. gata3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells.
Chen HJ; Huang RL; Liew PL; Su PH; Chen LY; Weng YC; Chang CC; Wang YC; Chan MW; Lai HC
Int J Cancer; 2018 Dec; 143(12):3106-3119. PubMed ID: 30006927
[TBL] [Abstract] [Full Text] [Related]
11. Mammary Analogue Secretory Carcinoma of the Thyroid Mimicking Locally Advanced Papillary Thyroid Carcinoma: A Rare Case Report.
Liao H; Khan A; Miron PM; Cornejo KM
Int J Surg Pathol; 2018 Aug; 26(5):459-463. PubMed ID: 29228842
[TBL] [Abstract] [Full Text] [Related]
12. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract] [Full Text] [Related]
13. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and gata3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract] [Full Text] [Related]
14. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer.
De Monte L; Reni M; Tassi E; Clavenna D; Papa I; Recalde H; Braga M; Di Carlo V; Doglioni C; Protti MP
J Exp Med; 2011 Mar; 208(3):469-78. PubMed ID: 21339327
[TBL] [Abstract] [Full Text] [Related]
15. Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients.
Tassi E; Braga M; Longhi R; Gavazzi F; Parmiani G; Di Carlo V; Protti MP
PLoS One; 2009 Oct; 4(10):e7234. PubMed ID: 19798410
[TBL] [Abstract] [Full Text] [Related]
16. Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients.
Tassi E; Gavazzi F; Albarello L; Senyukov V; Longhi R; Dellabona P; Doglioni C; Braga M; Di Carlo V; Protti MP
J Immunol; 2008 Nov; 181(9):6595-603. PubMed ID: 18941250
[TBL] [Abstract] [Full Text] [Related]
17. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry.
Tetsche MS; Nørgaard M; Skriver MV; Andersen ES; Lash TL; Sørensen HT
Eur J Gynaecol Oncol; 2005; 26(3):266-70. PubMed ID: 15991523
[TBL] [Abstract] [Full Text] [Related]
18. Gene expression patterns in ovarian carcinomas.
Schaner ME; Ross DT; Ciaravino G; Sorlie T; Troyanskaya O; Diehn M; Wang YC; Duran GE; Sikic TL; Caldeira S; Skomedal H; Tu IP; Hernandez-Boussard T; Johnson SW; O'Dwyer PJ; Fero MJ; Kristensen GB; Borresen-Dale AL; Hastie T; Tibshirani R; van de Rijn M; Teng NN; Longacre TA; Botstein D; Brown PO; Sikic BI
Mol Biol Cell; 2003 Nov; 14(11):4376-86. PubMed ID: 12960427
[TBL] [Abstract] [Full Text] [Related]
19. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
[TBL] [Abstract] [Full Text] [Related]